Abstract
Purpose
Malignancy-associated gastroparesis (MAG) is a cause of morbidity in cancer patients but therapies are lacking. Gastric electrical stimulation (GES) is a novel treatment for MAG. Here, we describe 19 patients with MAG who underwent temporary GES placement.
Patients and methods
Nineteen patients (6 males, 13 females) with various malignancies were reviewed for symptom scores and physiologic measures at baseline and after temporary GES placement. Symptoms were scored by three variables: nausea (N), vomiting (V), and GI total symptom score (TSS). Physiologic profiles were measured by solid and liquid phase gastric emptying scans (GET) at 1, 2, and 4 h and cutaneous electrogastrogram (EGG) and mucosal electrogram (EG) frequencies. Symptoms were measured for 5 days after temporary endoscopic GES placement, and measures were repeated post GES placement.
Results
Baseline GET results displayed delayed gastric emptying in 16 of 19 patients (mean solid retention 21.7 % at 4 h, normal <10 %; mean liquid retention 10.4 % at 4 h, normal <5 %). Cutaneous EGG (mean frequency 5.5 cpm) and EG (mean proximal frequency 5.1 cpm; mean distal frequency 5.1 cpm) showed evidence of neuromuscular dysfunction (normal 2.5–3.3 cpm). Symptom scores in N, V, and TSS showed statistically significant reduction after GES placement.
Conclusion
A small sample of patients with MAG and receiving temporary GES experienced symptom improvement, with less change on gastric emptying time or gastric electrical amplitude or frequency. GES may provide a potential therapeutic option for symptomatic management of MAG and evaluation of these MAG patients after permanent GES placement is ongoing. Prospective studies of MAG using temporary and permanent GES may be warranted.
Similar content being viewed by others
References
Shafi MA, Nasser E, Javle MM (2015) Malignancy-associated gastroparesis: pathophysiology and management. In: Savarese D (ed) UpToDate. MA, Waltham
Pasricha PJ (2007) The riddle, mystery, and enigma of gastroparesis. J Support Oncol 5:368–370
Shah H, Kedar A, McElmurray L, et al. (2014) Gastric stimulator, a novel approach in treating malignancy associated gastroparesis. Gastroenterology 146:S695–S696
Donthireddy KR, Ailawadhi S, Nasser E, et al. (2007) Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. J Support Oncol 5:355–363
Abell T, McCallum R, Hocking M, et al. (2003) Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125:421–428
Wood GJ, Shega JW, Lynch B, et al. (2007) Management of intractable nausea and vomiting in patients at the end of life: “I was feeling nauseous all of the time... nothing was working”. JAMA 298:1196–1207
Camilleri M, Parkman HP, Shafi MA, et al. (2013) Clinical guideline: management of gastroparesis. Am J Gastroenterol 108:18–37 quiz 38
Abell TL, Johnson WD, Kedar A, et al. (2011) A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc 74:496–503 e493
Tougas G, Eaker EY, Abell TL, et al. (2000) Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 95:1456–1462
Guo JP, Maurer AH, Fisher RS, et al. (2001) Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 46:24–29
Hasler WL (2009) Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 21:229–243
Pasricha PJ, Colvin R, Yates K, et al. (2011) Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 9(7):567–576 e1-4
Acknowledgments
The authors would like to thank the staff of the University of Mississippi Medical Center as well as the University of Louisville, especially the GI Motility Clinic at the Jewish Hospital/Kentucky One. They would also like to thank Catherine McBride for the help with manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Abell has been a licensor, investigator, and consultant to Medtronic. Certain aspects of the technology of temporary gastric electrical stimulation are covered by intellectual property awarded to the University of Mississippi, now licensed to ADEPT-GI.
Rights and permissions
About this article
Cite this article
Shah, H., Wendorf, G., Ahmed, S. et al. Treating an oft-unrecognized and troublesome entity: using gastric electrical stimulation to reduce symptoms of malignancy-associated gastroparesis. Support Care Cancer 25, 27–31 (2017). https://doi.org/10.1007/s00520-016-3375-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3375-z